Lv1
100 积分 2023-03-16 加入
Safety, tolerability, and pharmacokinetics of HL-300, a novel topical pan-JAK inhibitor, in healthy Chinese adults: a first-in-human, randomized, double-blind, placebo-controlled phase I trial
2天前
已完结
Randomized dose-finding study of anti-KIT barzolvolimab in patients with chronic spontaneous urticaria
27天前
已完结
Osteoarthritis: Joint Anatomy, Physiology, and Pathobiology
1个月前
已完结
Organ-specific tumor dynamics predict survival of patients with metastatic colorectal cancer
1个月前
已完结
Long‐term efficacy of abrocitinib in patients with moderate‐to‐severe atopic dermatitis to 2 years
1个月前
已完结
Peficitinib halts acute kidney injury via JAK/STAT3 and growth factors immunomodulation
3个月前
已完结
Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
3个月前
已完结
Clinical characteristics and causes of pruritus in cats: a multicentre study on feline hypersensitivity‐associated dermatoses
3个月前
已完结
Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
4个月前
已完结
皖公网安备34019202002308
